Beneficial Role of Aminoguanidine on Acute Cardiomyopathy Related to Doxorubicin-treatment

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2006 Apr 14

PMID 16612575

Citations 6

Authors

Yilmaz Cigremis

Hakan Parlakpinar

Alaadin Polat

Cemil Colak

Feral Ozturk

Engin Sahna

Necip Ermis

Ahmet Acet

Affiliations

Soon will be listed here.

Abstract

Doxorubicin (DOX) is a broad-spectrum anthracycline antibiotic that has cardiotoxicity as a major side effect. One mechanism of this toxicity is believed to involve the reactive oxygen radical species (ROS); these agents likely account for the pathophysiology of DOX-induced cardiomyopathy. Aminoguanidine (AG) is an effective antioxidant and free radical scavenger which has long been known to protect against ROS formation. We investigated the effects of AG on DOX-induced changes in thiobarbituric acid reactive substances (TBARS) and reduced glutathione (GSH) content. The rats were divided into four groups:1) Control; 2) DOX group; injected intraperitoneally (i.p.) with DOX 20 mg/kg in a single dose 3) AG-treated group; injected i.p. in single dose of 20 mg/kg DOX plus 100 mg/kg AG 1 h before the DOX for 3 days, 4) AG group; injected i.p. with AG 100 mg/kg for 3 days. DOX administration to control rats increased TBARS and decreased GSH levels. AG administration before DOX injection caused significant decrease in TBARS and increase in GSH levels in the heart tissue when compared with DOX only. Morphological changes, including severe myocardial fibrosis and inflammatory cell infiltration were clearly observed in the DOX-treated heart. AG reversed the DOX-induced heart damage. Therefore AG could protect the heart tissue against free radical injury. The application of AG during cancer chemotherapy may attenuate tissue damage and improve the therapeutic index of DOX.

Citing Articles

Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients.

Hao W, Shi Y, Qin Y, Sun C, Chen L, Wu C Integr Cancer Ther. 2020; 19:1534735420945017.

PMID: 32729334 PMC: 7491211. DOI: 10.1177/1534735420945017.

Korean Red Ginseng enhances cardiac hemodynamics on doxorubicin-induced toxicity in rats.

Jang Y, Lee D, Hossain M, Aravinthan A, Kang C, Kim N J Ginseng Res. 2020; 44(3):483-489.

PMID: 32372870 PMC: 7195579. DOI: 10.1016/j.jgr.2019.03.002.

Aminoguanidine reduces diabetes-associated cardiac fibrosis.

Magdaleno F, Blajszczak C, Charles-Nino C, Guadron-Llanos A, Vazquez-Alvarez A, Miranda-Diaz A Exp Ther Med. 2019; 18(4):3125-3138.

PMID: 31572553 PMC: 6755450. DOI: 10.3892/etm.2019.7921.

Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial.

Hao W, Liu S, Qin Y, Sun C, Chen L, Wu C Trials. 2017; 18(1):386.

PMID: 28830541 PMC: 5568055. DOI: 10.1186/s13063-017-2140-z.

Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.

Aissiou M, Perie D, Cheriet F, Dahdah N, Laverdiere C, Curnier D Int J Cardiovasc Imaging. 2013; 29(7):1459-76.

PMID: 23744127 DOI: 10.1007/s10554-013-0248-0.

References

Giardino I, Fard A, Hatchell D, Brownlee M . Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes. 1998; 47(7):1114-20. DOI: 10.2337/diabetes.47.7.1114. View

Li T, Danelisen I, Singal P . Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Mol Cell Biochem. 2002; 232(1-2):19-26. DOI: 10.1023/a:1014862912783. View

Garcia J, Reiter R, Guerrero J, Escames G, Yu B, Oh C . Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 1997; 408(3):297-300. DOI: 10.1016/s0014-5793(97)00447-x. View

Sugimoto K, Yagihashi S . Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc Res. 1997; 53(2):105-12. DOI: 10.1006/mvre.1996.2002. View

Mostafa A, Nagi M, Al Rikabi A, Al-Shabanah O, El-Kashef H . Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats. Res Commun Mol Pathol Pharmacol. 2001; 106(3):193-202. View

Boucher F, Coudray C, Tirard V, Barandier C, Tresallet N, Favier A . Oral selenium supplementation in rats reduces cardiac toxicity of adriamycin during ischemia and reperfusion. Nutrition. 1995; 11(5 Suppl):708-11. View

Sahna E, Parlakpinar H, Ozer M, Ozturk F, Ozugurlu F, Acet A . Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations. J Pineal Res. 2003; 35(4):257-61. DOI: 10.1034/j.1600-079x.2003.00084.x. View

Yildiz G, Demiryurek A, Sahin-Erdemli I, Kanzik I . Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol. 1998; 124(5):905-10. PMC: 1565473. DOI: 10.1038/sj.bjp.0701924. View

Singal P, Iliskovic N . Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998; 339(13):900-5. DOI: 10.1056/NEJM199809243391307. View

10.

Misko T, MOORE W, Kasten T, Nickols G, Corbett J, Tilton R . Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 1993; 233(1):119-25. DOI: 10.1016/0014-2999(93)90357-n. View

11.

Kaul N, Singal P . Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation. 1994; 89(6):2829-35. DOI: 10.1161/01.cir.89.6.2829. View

12.

Agapito M, Antolin Y, del Brio M, Lopez-Burillo S, Pablos M, Recio J . Protective effect of melatonin against adriamycin toxicity in the rat. J Pineal Res. 2001; 31(1):23-30. DOI: 10.1034/j.1600-079x.2001.310104.x. View

13.

Wozniak G, Anuszewska E . Influence of vitamins C and E on cytotoxic activity of adriamycin in chosen cell cultures. Acta Pol Pharm. 2002; 59(1):31-5. View

14.

Pacher P, Liaudet L, Bai P, Mabley J, Kaminski P, Virag L . Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation. 2003; 107(6):896-904. DOI: 10.1161/01.cir.0000048192.52098.dd. View

15.

Aoki K, Ohmori M, Takimoto M, Ota H, Yoshida T . Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol. 1998; 336(1):43-9. DOI: 10.1016/s0014-2999(97)01230-2. View

16.

Al-Shabanah O, Alam K, Nagi M, Al-Rikabi A, Al-Bekairi A . Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. Life Sci. 2000; 66(3):265-70. DOI: 10.1016/s0024-3205(99)00589-5. View

17.

Szabo C, Ferrer-Sueta G, Zingarelli B, Southan G, Salzman A, Radi R . Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem. 1997; 272(14):9030-6. DOI: 10.1074/jbc.272.14.9030. View

18.

Fadillioglu E, Erdogan H, Sogut S, Kuku I . Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol. 2003; 23(1):71-4. DOI: 10.1002/jat.889. View

19.

Naidu M, Kumar K, Mohan I, Sundaram C, Singh S . Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice. Indian J Exp Biol. 2003; 40(8):894-900. View

20.

Parlakpinar H, Sahna E, Ozer M, Ozugurlu F, Vardi N, Acet A . Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury. J Pineal Res. 2002; 33(3):161-6. DOI: 10.1034/j.1600-079x.2002.02910.x. View